Implant Sciences Wins Contract in Nigeria for Explosives Trace Detectors
WILMINGTON, MA, Jan 03, 2013 (MARKETWIRE via COMTEX) --
Implant Sciences Corporation (OTCQB: IMSC), a high technology
supplier of systems and sensors for homeland security and defense
markets, today announced it has won a competitive contract for the
sale of Quantum Sniffer(TM) QS-H150 handheld explosives trace
detectors to a corporate customer for critical infrastructure
protection in Nigeria.
"Our systems have developed a reputation of excellence in Nigeria.
The Quantum Sniffer's ease-of-use and detection capability across a
wide range of environmental conditions are key value drivers for
customers," stated Darryl Jones, Implant Sciences' Vice President of
Sales and Marketing.
"Critical infrastructure protection is a growing market segment for
our Company. Our systems' minimal supply and maintenance requirements
are especially attractive to customers in Africa, the Middle East,
and Asia," added Glenn D. Bolduc, Implant Sciences' President and
About the Quantum Sniffer(TM) QS-H150 Handheld Explosives Trace
The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS)
technology, providing fast, accurate detection of trace amounts of a
wide variety of military, commercial, and homemade explosives. Built
with no radioactive materials and featuring a low-maintenance,
self-calibrating, and self-clearing design, the QS-H150 provides very
high levels of operational availability. The QS-H150 has been proven
to perform well in a wide variety of temperatures and challenging
environments, from humid jungles to dry, sand swept deserts.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated
sensors and systems for Security, Safety, and Defense (SS&D) markets.
The Company has developed proprietary technologies used in its
commercial explosive and narcotics trace detection systems which ship
to a growing number of locations domestically and internationally.
Implant Sciences' QS-H150 portable explosives trace detector has
received Qualified Anti-Terrorism Technology Designation and the
Company's QS-B220 desktop explosives and drugs trace detector has
received a Developmental Testing & Evaluation (DT&E) Designation by
the U.S. Department of Homeland Security under the Support
Anti-terrorism by Fostering Effective Technology Act of 2002 (the
SAFETY Act). For further details on the Company and its products,
please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking statements,"
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Such statements are based on management's current
expectations and are subject to risks and uncertainties that could
cause the Company's actual results to differ materially from the
forward-looking statements. Such risks and uncertainties include, but
are not limited to, the risks that our explosives detection products
and technologies (including any new products we may develop) may not
be accepted by the Transportation Security Administration or by other
U.S. or foreign government and law enforcement agencies or commercial
consumers of security products; economic, political and other risks
associated with international sales and operations could adversely
affect our sales; our business is subject to intense competition and
rapid technological change; the risks that our markets are subject to
technological change and that our success depends on our ability to
develop and introduce new products; and other risks and uncertainties
described in our filings with the Securities and Exchange Commission,
including its most recent Forms 10-K, 10-Q and 8-K. Such statements
are based on management's current expectations and assumptions which
could differ materially from the forward-looking statements.
Implant Sciences Corporation
SOURCE: Implant Sciences Corporation
[ Back To TMCnet.com's Homepage ]